Scientists found that nasal cells act as a first line of defense against the common cold, working together to block rhinovirus soon after infection. A fast antiviral response can stop the virus before symptoms appear. If that response is weakened or delayed, the virus spreads and causes inflammation and breathing problems. The study highlights why the body’s reaction matters more than the virus alone.
Quelle: ScienceDaily | COPD
Titelbild/Grafik: ScienceDaily News
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Severe COVID or flu may raise lung cancer risk years later
- New oxygen gel could prevent amputation in diabetic wound patients
- Scientists discover why high altitude protects against diabetes
- Scientists finally explain why chronic constipation treatments often fail
- Why some people get bad colds and others don’t
- Stanford scientists found a way to regrow cartilage and stop arthritis
- Half of heart attacks strike people told they’re low risk
- A hidden breathing problem may be behind chronic fatigue’s crushing exhaustion
- New breath sensor detects diabetes quickly and easily
- Can zebrafish help humans regrow hearing cells?
